Bolt Biotherapeutics's total assets for Q3 2025 were $65.05M, a decrease of -13.84% from the previous quarter. BOLT total liabilities were $32.95M for the fiscal quarter, a -10.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.